(a) whether the Organisation of Pharmaceutical Producers of India has asked the Government
to fix the ceiling prices separately for imported formulations because making the same drugs
outside the country is more costly; and
(b) if so, the details thereof and the reaction of the Government thereto?
MINISTER OF STATE (INDEPENDENT CHARGE) IN THE MINISTRY OF CHEMICALS AND FERTILIZERS AND
MINISTER OF STATE (INDEPENDENT CHARGE) IN THE MINISTRY OF STATISTICS AND PROGRAMME
IMPLEMENTATION (SHRI SRIKANT KUMAR JENA)
(a) & (b) The Organisation of Pharmaceutical Producers of India (OPPI) had given the following
suggestions/inputs on draft National Pharmaceutical Pricing Policy 2011 (NPPP-2011):
“Import products have different cost-structure and are not comparable to locally manufactured
drugs, consequently, imported formulations included in National List of Essential Medicines-2011
(NLEM)-2011) should be placed in a separate category and a separate ceiling price should be
fixed for them.â€
These suggestions of OPPI were placed before the Group of Ministers(GoM). Based on the
recommendations of GoM, National Pharmaceutical Pricing Policy 2012 (NPPP-2012) was
formulated and placed before the Cabinet. The Cabinet considered NPPP-2012 in its meeting
held on 22.11.2012 and based on the approval of the Cabinet the NPPP-2012 was notified on
712.2012.